Frida Dangardt

Frida Dangardt

Auto-generated profile, based on publicly available information

Frida Dangardt

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2016 in Addiction
Verified
Journal Article
Closed access
PDF file
TNTimothy S. Naimi
Timothy S. Naimi
TSTim Stockwell
Tim Stockwell
JZJinhui Zhao
Jinhui Zhao
ZXZiming Xuan
Ziming Xuan
FDFrida Dangardt
Frida Dangardt
TCTanya Chikritzhs
Tanya Chikritzhs

1 October 2010 in Atherosclerosis
Verified
Journal Article
Closed access
FDFrida Dangardt
Frida Dangardt
WOWalter Osika
Walter Osika
YCYun Chen
Yun Chen
UNUlf Nilsson
Ulf Nilsson
LGLi-Ming Gan
Li-Ming Gan
PFPeter Friberg
Peter Friberg

22 January 2015 in Addiction
Verified
Journal Article
Closed access
PDF file
TCTanya Chikritzhs
Tanya Chikritzhs
TSTim Stockwell
Tim Stockwell
TNTimothy Naimi
Timothy Naimi
SASven Andreasson
Sven Andreasson
FDFrida Dangardt
Frida Dangardt
WLWenbin Liang
Wenbin Liang

12 August 2008 in Clinical Physiology and Functional Imaging
Verified
Journal Article
Closed access
PDF file
FDFrida Dangardt
Frida Dangardt
WOWalter Osika
Walter Osika
RVReinhard Volkmann
Reinhard Volkmann
LGLi‐Ming Gan
Li‐Ming Gan
PFPeter Friberg
Peter Friberg

1 February 2021 in JACC: Cardiovascular Imaging
Verified
Journal Article
Open access
SCScott T. Chiesa
Scott T. Chiesa
MCMarietta Charakida
Marietta Charakida
GGGeorgios Georgiopoulos
Georgios Georgiopoulos
FDFrida Dangardt
Frida Dangardt
KWKaitlin H. Wade
Kaitlin H. Wade
JDJohn E. Deanfield
John E. Deanfield
This study characterized the determinants of carotid intima-media thickness (cIMT) in a large (n > 4,000) longitudinal cohort of healthy young people age 9 to 21 years. Greater cIMT is commonly used in the young as a marker of subclinical atherosclerosis, but its evolution at this age is still poorly understood. Associations between cardiovascular risk factors and cIMT were investigated in both longitudinal (ages 9 to 17 years) and cross-sectional (ages 17 and 21 years) analyses, with the latter also related to other measures of carotid structure and stress. Additional use of ultra-high frequency ultrasound in the radial artery at age 21 years allowed investigation of the distinct layers (i.e., intima or media) that may underlie observed differences. Fat-free mass (FFM) and systolic blood pressure were the only modifiable risk factors positively associated with cIMT (e.g., mean difference in cIMT per 1-SD increase in FFM at age 17: 0.007 mm: 95% confidence interval [CI]: 0.004 to 0.010; p < 0.001), whereas fat mass was negatively associated with cIMT (difference: -0.0032; 95% CI: 0.004 to -0.001; p = 0.001). Similar results were obtained when investigating cumulative exposure to these factors throughout adolescence. An increase in cIMT maintained circumferential wall stress in the face of increased mean arterial pressure when increases in body mass were attributable to increased FFM, but not fat mass. Risk factor-associated differences in the radial artery occurred in the media alone, and there was little evidence of a relationship between intimal thickness and any risk factor. Subtle changes in cIMT in the young may predominantly involve the media and represent physiological adaptations as opposed to subclinical atherosclerosis. Other vascular measures may be more appropriate for the identification of arterial disease before adulthood.

1 July 2019 in The Lancet Child & Adolescent Health
Verified
Journal Article
Open access
FDFrida Dangardt
Frida Dangardt
MCMarietta Charakida
Marietta Charakida
GGGeorgios Georgiopoulos
Georgios Georgiopoulos
SCScott T Chiesa
Scott T Chiesa
ARAlicja Rapala
Alicja Rapala
JDJohn E Deanfield
John E Deanfield
The link between adiposity, metabolic abnormalities, and arterial disease progression in children and adolescents remains poorly defined. We aimed to assess whether persistent high adiposity levels are associated with increased arterial stiffness in adolescence and any mediation effects by common metabolic risk factors. We included participants from the Avon Longitudinal Study of Parents and Children (ALSPAC) who had detailed adiposity measurements between the ages 9-17 years and arterial stiffness (carotid to femoral pulse wave velocity [PWV]) measured at age 17 years. Body-mass index (BMI) and waist-to-height ratio were calculated from weight, height, and waist circumference measurements whereas fat mass was assessed using repeated dual-energy x-ray absorptiometry (DEXA) scans. We used total and trunk fat mass indices (FMIs) to classify participants as normal (75th percentile) FMI. We classified participants as being metabolically unhealthy if they had three or more of the following risk factors: high levels of systolic blood pressure, triglycerides, or glucose (all >75th percentile) or low levels of high-density lipoprotein (<25th percentile). We used multivariable linear regression analysis to assess the relationship between PWV and exposure to adiposity, and tested for linear trend of PVW levels across ordinal groups. We used latent class growth mixture modelling analysis to assess the effect of longitudinal changes in adiposity indices through adolescence on arterial stiffness. We studied 3423 participants (1866 [54·5%] female and 1557 [45·5%] male). Total fat mass was positively associated with PWV at age 17 years (0·004 m/s per kg, 95% CI 0·001-0·006; p=0·0081). Persistently high total FMI and trunk FMI between ages 9 and 17 years were related to greater PWV (0·15 m/s per kg/m2, 0·05-0·24; p=0·0044 and 0·15 m/s per kg/m2, 0·06-0·25; p=0·0021) compared with lower FMI. Metabolic abnormalities amplified the adverse effect of high total FMI on arterial stiffness (PWV 6·0 m/s [95% CI 5·9-6·0] for metabolically healthy participants and 6·2 m/s [5·9-6·4] for metabolically unhealthy participants). Participants who restored normal total FMI in adolescence (PWV 5·8 m/s [5·7-5·9] for metabolically healthy and 5·9 m/s [5·6-6·1] for metabolically unhealthy) had comparable PWV to those who had normal FMI throughout (5·7 m/s [5·7-5·8] for metabolically healthy and 5·9 m/s [5·8-5·9] for metabolically unhealthy). Persistently high fat mass during adolescence was associated with greater arterial stiffness and was further aggravated by an unfavourable metabolic profile. Reverting to normal FMI in adolescence was associated with normal PWV, suggesting adolescence as an important period for interventions to tackle obesity in the young to maximise long-term vascular health. UK Medical Research Council, Wellcome Trust, British Heart Foundation, and AFA Insurances.